Axcella Health Inc.
NASDAQ:AXLA
4.58 (USD) • At close May 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 1.224 | 1.433 | 13.257 | 13.317 | 16.866 | 13.544 | 12.467 | 10.13 | 10.298 | 10.24 | 10.598 | 7.541 | 8.565 | 10.335 | 10.758 | 12.157 | 9.343 | 7.563 | 7.877 | 6.147 | 6.007 | 5.455 |
General & Administrative Expenses
| 2.319 | 2.75 | 3.5 | 3.776 | 3.753 | 4.786 | 4.736 | 4.773 | 4.946 | 4.256 | 3.869 | 4.184 | 4.619 | 4.125 | 4.582 | 4.84 | 4.728 | 3.468 | 1.286 | 2.087 | 2.901 | 2.136 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 2.319 | 2.75 | 3.5 | 3.776 | 3.753 | 4.786 | 4.736 | 4.773 | 4.946 | 4.256 | 3.869 | 4.184 | 4.619 | 4.125 | 4.582 | 4.84 | 4.728 | 3.468 | 1.286 | 2.087 | 2.901 | 2.136 |
Other Expenses
| 0 | 0.067 | -0.01 | -0.043 | 0 | -0.027 | 0.001 | 0 | -0.005 | 0 | -12.498 | -0.712 | 4.142 | -0.549 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 3.543 | 4.183 | 16.757 | 17.093 | 20.619 | 18.33 | 17.203 | 14.903 | 15.244 | 14.496 | 14.467 | 11.725 | 13.184 | 14.46 | 15.34 | 16.997 | 14.071 | 11.031 | 9.163 | 8.234 | 8.908 | 7.591 |
Operating Income
| -3.543 | -4.183 | -20.946 | -17.093 | -20.619 | -18.33 | -17.203 | -14.903 | -15.244 | -14.496 | -14.467 | -11.725 | -13.184 | -14.46 | -15.34 | -16.997 | -14.071 | -11.031 | -9.163 | -8.234 | -8.908 | -7.591 |
Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| 0.13 | 0.207 | -2.054 | -0.748 | -0.687 | -0.709 | -0.688 | -0.71 | -0.691 | -0.693 | -0.722 | -0.712 | -0.708 | -0.549 | -0.373 | -0.307 | -0.376 | -0.542 | -0.599 | -0.55 | -0.515 | -0.509 |
Income Before Tax
| -3.413 | -3.976 | -23 | -17.841 | -21.306 | -19.039 | -17.891 | -15.613 | -15.935 | -15.189 | -15.189 | -12.437 | -13.892 | -15.009 | -15.713 | -17.304 | -14.447 | -11.573 | -9.762 | -8.784 | -9.423 | -8.1 |
Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 0 | -0.207 | 1.257 | 0.748 | 0.687 | 0.709 | 0.713 | 0.032 | 0.618 | 0.035 | -0.076 | -0.092 | 0 | -0.131 | 0.263 | 0 | 0 | 0.542 | 0.599 | 0.55 | 0.515 | 0.509 |
Net Income
| -3.413 | -3.769 | -24.257 | -18.589 | -21.993 | -19.748 | -17.891 | -15.613 | -15.935 | -15.189 | -15.189 | -12.437 | -13.892 | -15.009 | -15.713 | -17.304 | -14.447 | -11.573 | -9.762 | -8.784 | -9.423 | -8.1 |
Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -1.25 | -0.051 | -0.45 | -0.35 | -0.42 | -0.48 | -0.46 | -0.41 | -0.42 | -0.4 | -0.4 | -0.34 | -0.48 | -0.65 | -0.68 | -0.75 | -0.95 | -0.5 | -0.42 | -0.53 | -0.57 | -0.49 |
EPS Diluted
| -1.16 | -0.051 | -0.45 | -0.35 | -0.42 | -0.48 | -0.46 | -0.41 | -0.42 | -0.4 | -0.4 | -0.34 | -0.48 | -0.65 | -0.68 | -0.75 | -0.95 | -0.5 | -0.42 | -0.53 | -0.57 | -0.49 |
EBITDA
| -3.403 | -4.183 | -10.967 | -16.882 | -20.619 | -18.258 | -17.128 | -14.822 | -15.244 | -14.432 | -14.467 | -11.725 | -13.064 | -14.46 | -15.34 | -16.843 | -13.91 | -10.777 | -8.886 | -8.012 | -8.64 | -7.273 |
EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |